Colpen Products Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 54 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.86 M
- Revenue Growth 233.49%
- Profit Growth 128.48%
- Ebitda 93.30%
- Net Worth 68.14%
- Total Assets -10.14%
About Colpen Products
Colpen Products Pvt Ltd (CPPL) was founded in India on 12 November 1970 and has a glorious history of 54 years and two months.Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹0.86 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sunit Nagarsheth, Yash Nagarsheth, and Gargi Shah serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36991GJ1970PTC001805
-
Company No.
001805
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Nov 1970
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Colpen Products?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Nagarsheth
|
Director | 30-Sep-2018 | Current |
|
Sunit Nagarsheth
|
Director | 29-Dec-2014 | Current |
|
Gargi Shah
|
Director | 31-Jul-1998 | Current |
Financial Performance of Colpen Products.
Colpen Products Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 233.49% increase. The company also saw a substantial improvement in profitability, with a 128.48% increase in profit. The company's net worth Soared by an impressive increase of 68.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Colpen Products?
In 2021, Colpen Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
C3 Med-Tech Private LimitedYash Nagarsheth and Gargi Shah are mutual person
-
Lead Slips Products LlpSunit Nagarsheth and Gargi Shah are mutual person
Charges (Loans)
₹0
₹0.86 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.05 Cr
- Citi Bank : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jan 2009 | Bank Of India | ₹0.50 M | Satisfied |
| 25 Mar 2005 | Citi Bank | ₹0.36 M | Satisfied |
How Many Employees Work at Colpen Products?
Unlock and access historical data on people associated with Colpen Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Colpen Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Colpen Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
